Testing effectiveness (Phase 2)Looking for participantsNCT05990803
What this trial is testing
BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies
Who this might be right for
Cervical Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 130